Company intelligence
Allterum Therapeutics
Developing Treatments for ALL.
Biotechnology Research
Houston, US
8 employees
Founded 2018
5 public signals
About Allterum Therapeutics
Allterum Therapeutics is a biopharmaceutical company developing an immunotherapy for pediatric acute lymphoblastic leukemia.
Verified activity
Signals from Allterum Therapeutics
5 published signals
Presence & Recognition
Allterum Therapeutics team members met with Kirill Larin, Chair of BME and Tina Kazemi, Ph.D. at Fannin.
Reported by Atul Varadhachary
Presence & Recognition
Allterum Therapeutics leadership from Allterum Therapeutics, Goldenrod Therapeutics, and Raptamer Therapeutics joined the company.
Reported by Atul Varadhachary
Presence & Recognition
Allterum Therapeutics intern Giovanni Victorio joined Brevitest after starting as an intern at Brevitest.
Reported by Atul Varadhachary
People
Allterum Therapeutics employee Atul Varadhachary joined the University of Houston as an adjunct faculty member.
Reported by Atul Varadhachary
Partnerships
Allterum Therapeutics received support from Michael Weingarten, Brittany Connors, and PMP to Fannin.
Reported by Atul Varadhachary